JP2008037814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008037814A5 JP2008037814A5 JP2006215485A JP2006215485A JP2008037814A5 JP 2008037814 A5 JP2008037814 A5 JP 2008037814A5 JP 2006215485 A JP2006215485 A JP 2006215485A JP 2006215485 A JP2006215485 A JP 2006215485A JP 2008037814 A5 JP2008037814 A5 JP 2008037814A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxide
- hydroxyl radical
- metal oxide
- hydroxyl
- virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl radical Chemical class [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 claims description 123
- 239000000843 powder Substances 0.000 claims description 77
- 229910044991 metal oxide Inorganic materials 0.000 claims description 55
- 150000004706 metal oxides Chemical class 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 48
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 48
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 46
- 239000000463 material Substances 0.000 claims description 35
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 27
- 239000011707 mineral Substances 0.000 claims description 27
- 239000000395 magnesium oxide Substances 0.000 claims description 23
- 230000000840 anti-viral Effects 0.000 claims description 22
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- 239000010459 dolomite Substances 0.000 claims description 12
- 229910000514 dolomite Inorganic materials 0.000 claims description 12
- 239000007787 solid Substances 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 7
- 229910001038 basic metal oxide Inorganic materials 0.000 claims description 7
- AXCZMVOFGPJBDE-UHFFFAOYSA-L Calcium hydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 6
- VTHJTEIRLNZDEV-UHFFFAOYSA-L Magnesium hydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 6
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 6
- 238000001354 calcination Methods 0.000 claims description 6
- 239000000920 calcium hydroxide Substances 0.000 claims description 6
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 6
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 6
- 239000000347 magnesium hydroxide Substances 0.000 claims description 6
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 5
- 239000002002 slurry Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 239000000243 solution Substances 0.000 claims description 4
- 238000004438 BET method Methods 0.000 claims description 3
- UUCCCPNEFXQJEL-UHFFFAOYSA-L Strontium hydroxide Chemical compound [OH-].[OH-].[Sr+2] UUCCCPNEFXQJEL-UHFFFAOYSA-L 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- 239000000908 ammonium hydroxide Substances 0.000 claims description 3
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 claims description 3
- 229910001863 barium hydroxide Inorganic materials 0.000 claims description 3
- 239000000292 calcium oxide Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 229910001866 strontium hydroxide Inorganic materials 0.000 claims description 3
- 229910000314 transition metal oxide Inorganic materials 0.000 claims description 3
- 238000010304 firing Methods 0.000 claims 3
- 230000000887 hydrating Effects 0.000 claims 3
- 230000000630 rising Effects 0.000 claims 1
- 241000700605 Viruses Species 0.000 description 79
- 238000006243 chemical reaction Methods 0.000 description 41
- 230000002779 inactivation Effects 0.000 description 29
- 230000000415 inactivating Effects 0.000 description 12
- 239000002245 particle Substances 0.000 description 11
- 101710033747 S6 Proteins 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 10
- -1 chlorite anion Chemical class 0.000 description 9
- 150000004679 hydroxides Chemical class 0.000 description 9
- 239000003443 antiviral agent Substances 0.000 description 8
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000004435 EPR spectroscopy Methods 0.000 description 7
- 241000712461 unidentified influenza virus Species 0.000 description 6
- 239000011575 calcium Substances 0.000 description 5
- 230000002209 hydrophobic Effects 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 229960003563 Calcium Carbonate Drugs 0.000 description 4
- 241000315672 SARS coronavirus Species 0.000 description 4
- 102000004965 antibodies Human genes 0.000 description 4
- 108090001123 antibodies Proteins 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229910001919 chlorite Inorganic materials 0.000 description 4
- 229910052619 chlorite group Inorganic materials 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical group [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 230000002458 infectious Effects 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 229910052742 iron Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- RNRMWTCECDHNQU-UHFFFAOYSA-N tert-butyl-[(1-oxidopyridin-4-ylidene)methyl]-oxoazanium Chemical compound CC(C)(C)[N+](=O)C=C1C=CN([O-])C=C1 RNRMWTCECDHNQU-UHFFFAOYSA-N 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 3
- 239000012298 atmosphere Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 230000001681 protective Effects 0.000 description 3
- 239000003638 reducing agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000000605 viral structures Anatomy 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 2
- PZZYQPZGQPZBDN-UHFFFAOYSA-N Aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 description 2
- OSVXSBDYLRYLIG-UHFFFAOYSA-N Chlorine dioxide Chemical compound O=Cl=O OSVXSBDYLRYLIG-UHFFFAOYSA-N 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L Magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 2
- 102000016350 Viral Proteins Human genes 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 238000006993 Weiss annulation reaction Methods 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- QBWCMBCROVPCKQ-UHFFFAOYSA-M chlorite Chemical compound [O-]Cl=O QBWCMBCROVPCKQ-UHFFFAOYSA-M 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 239000001095 magnesium carbonate Substances 0.000 description 2
- 239000011776 magnesium carbonate Substances 0.000 description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 2
- 230000000737 periodic Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- 238000001262 western blot Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004155 Chlorine dioxide Substances 0.000 description 1
- MAYPHUUCLRDEAZ-UHFFFAOYSA-N ClO dimer Chemical compound ClOOCl MAYPHUUCLRDEAZ-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N DPPH Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241000711950 Filoviridae Species 0.000 description 1
- 241000710831 Flavivirus Species 0.000 description 1
- 241000709721 Hepatovirus A Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 210000001331 Nose Anatomy 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 241000709664 Picornaviridae Species 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 108050006987 Poxvirus Proteins 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000024126 agglutination involved in conjugation with cellular fusion Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- YLFIGGHWWPSIEG-UHFFFAOYSA-N aminoxyl Chemical compound [O]N YLFIGGHWWPSIEG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000004164 analytical calibration Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019398 chlorine dioxide Nutrition 0.000 description 1
- 229910001902 chlorine oxide Inorganic materials 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective Effects 0.000 description 1
- 201000009910 diseases by infectious agent Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000003260 fluorescence intensity Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005003 food packaging material Substances 0.000 description 1
- 230000003301 hydrolyzing Effects 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 229910001853 inorganic hydroxide Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 load Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241001430294 unidentified retrovirus Species 0.000 description 1
- 230000003612 virological Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006215485A JP2008037814A (ja) | 2006-08-08 | 2006-08-08 | 抗ウイルス材及び環境反応型抗ウイルス材 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006215485A JP2008037814A (ja) | 2006-08-08 | 2006-08-08 | 抗ウイルス材及び環境反応型抗ウイルス材 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008037814A JP2008037814A (ja) | 2008-02-21 |
| JP2008037814A5 true JP2008037814A5 (fr) | 2010-07-22 |
Family
ID=39173249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006215485A Pending JP2008037814A (ja) | 2006-08-08 | 2006-08-08 | 抗ウイルス材及び環境反応型抗ウイルス材 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008037814A (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009098786A1 (fr) * | 2008-02-08 | 2009-08-13 | Mochigase Co., Ltd. | Substance antivirale, substance antivirale qui respecte l'environnement et substance antivirale contenue dans un matériau d'emballage |
| JP6172611B2 (ja) * | 2008-02-08 | 2017-08-02 | 典生 山本 | ヒドロキシルラジカルの発生方法、および、ヒドロキシルラジカル発生材 |
| WO2011016527A1 (fr) * | 2009-08-07 | 2011-02-10 | 株式会社モチガセ | Générateur de radicaux hydroxyle, matière antivirale utilisant le générateur de radicaux hydroxyle, et procédé de production de radicaux hydroxyle |
| WO2011058988A1 (fr) * | 2009-11-11 | 2011-05-19 | ユニチカ株式会社 | Feuille support d'un agent antiviral et procédé de fabrication de celle-ci |
| JP5398483B2 (ja) * | 2009-11-11 | 2014-01-29 | ユニチカ株式会社 | 衛生マスク |
| JP5791067B2 (ja) * | 2011-02-25 | 2015-10-07 | 田源石灰工業株式会社 | 畜舎用消毒剤 |
| EP3907261A1 (fr) * | 2020-05-06 | 2021-11-10 | Hecosol GmbH | Utilisation de revêtement antimicrobien |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4264163B2 (ja) * | 1998-06-29 | 2009-05-13 | 信秀 前田 | 無機系抗菌・防カビ剤、抗菌性樹脂組成物および抗菌性樹脂製品 |
| JP3802272B2 (ja) * | 1999-04-21 | 2006-07-26 | 大日精化工業株式会社 | 抗菌性樹脂組成物 |
| JP2004180991A (ja) * | 2002-12-04 | 2004-07-02 | Takenet:Kk | 洗濯槽クリーナー |
| JP2005036091A (ja) * | 2003-07-18 | 2005-02-10 | Mochise Denki Kk | プラスチック用添加剤及びプラスチック |
| EP1661460A4 (fr) * | 2003-08-12 | 2012-04-25 | Mochigase Electrical Equipment Co Ltd | Agent antiviral ainsi que fibres et elements antiviraux pourvus dudit agent |
-
2006
- 2006-08-08 JP JP2006215485A patent/JP2008037814A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2009098908A1 (ja) | 新規なヒドロキシルラジカル発生法、及び当該方法により発生したヒドロキシルラジカルを利用する抗ウイルス材 | |
| JP2008037814A5 (fr) | ||
| JP2008037814A (ja) | 抗ウイルス材及び環境反応型抗ウイルス材 | |
| Innocenzi et al. | Carbon-based antiviral nanomaterials: Graphene, C-dots, and fullerenes. A perspective | |
| Kumar et al. | Synthesis and characterization of bioactive hydroxyapatite–calcite nanocomposite for biomedical applications | |
| Cao et al. | Preparation of an orthodontic bracket coated with an nitrogen-doped TiO2-xNy thin film and examination of its antimicrobial performance | |
| US9108854B2 (en) | Biocidal colloidal dispersions of silica particles with silver ions adsorbed thereon | |
| JP6191842B2 (ja) | ヒドロキシルラジカル発生剤、ヒドロキシルラジカル発生剤を用いた抗ウイルス材及びヒドロキシルラジカル発生方法 | |
| JP6144413B2 (ja) | 亜塩素酸水含有ウイルス殺傷剤 | |
| Nene et al. | Synthetic preparations and atomic scale engineering of silver nanoparticles for biomedical applications | |
| Apalangya et al. | Rapid microwave synthesis of needle-liked hydroxyapatite nanoparticles via template directing ball-milled spindle-shaped eggshell particles | |
| WO2009104670A1 (fr) | Agent antimicrobien et antiviral et son procédé d'utilisation | |
| JP6172611B2 (ja) | ヒドロキシルラジカルの発生方法、および、ヒドロキシルラジカル発生材 | |
| Chaikina et al. | Mechanochemical Synthesis of SiO44–‐Substituted Hydroxyapatite, Part I–Kinetics of Interaction between the Components | |
| JP2021175741A (ja) | 無機抗ウイルス剤 | |
| JP6188628B2 (ja) | 嘔吐物処理剤 | |
| EP1390083B1 (fr) | Matiere a fonctions multiples emettant un rayonnement infrarouge lointain dans une phase aqueuse et son utilisation | |
| WO2015032217A1 (fr) | Application de polyoxométallate dans la préparation d'un désinfectant pour la stérilisation et l'élimination du formaldéhyde | |
| Lenji et al. | Phase formation, microstructure and setting time of MCM-48 mesoporous silica nanocomposites with hydroxyapatite for dental applications: effect of the Ca/P ratio | |
| Feng et al. | An amorphous calcium phosphate for drug delivery: ATP provides a phosphorus source and microwave-assisted hydrothermal synthesis | |
| WO2002087640A1 (fr) | Materiau multifonctionnel emettant un rayonnement infrarouge lointain dans une phase aqueuse | |
| KR102423077B1 (ko) | 고용량의 이산화염소 기체를 흡착할 수 있는 담체를 포함하는 방출 키트 및 그 담체를 제조할 수 있는 제조장치 | |
| Mariyam et al. | Physicochemical and antibacterial properties of ZnO/chitosan-modified mineral trioxide aggregate composites | |
| JP2007302587A (ja) | 鳥インフルエンザ予防剤 | |
| Rosaa et al. | Fighting viruses with materials science: Prospects for antivirus surfaces, drug delivery systems and artificial intelligence |